People News: MannKind, Ignite Health

Share this article:
MannKind appointed former Novartis global development head James Shannon to its board. Shannon, who is now president and CEO of Cerimon Pharmaceuticals, left Novartis in 2008. MannKind markets Afrezza for type 1 and type 2 diabetes as well as control of hyperglycemia, and has several products in Phase 1 clinical trials.

Ignite Health named Matt Brown president. Brown was previously COO. He replaces Jackie Herr, who is retiring from the Irvine, CA-based inVentiv Health company at the end of March.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media